Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Anterix Inc.ATEX · Entity 4597 | Director | August 04, 2026 | August 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Anterix Inc.
Report date August 04, 2026 · Filed August 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 14,367 |
Reported balance
After 2026-08-04 transaction · row 1
1 source rowRow 1 · 2026-08-04 · Grant · Acquired 1,598 · Balance 14,367 F1: The Shares will vest on the earlier of the 2027 Annual Meeting of shareholders and August 4, 2027, subject to the terms of the Restricted Stock Agreement. |
Filing footnotes · ownership attribution and instrument terms
F1: The Shares will vest on the earlier of the 2027 Annual Meeting of shareholders and August 4, 2027, subject to the terms of the Restricted Stock Agreement.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 04, 2026 Filed Aug 6, 2026 14:16 UTC | Anterix Inc. ATEX · Entity 4597 | GrantCommon Stock | 1,598 | $0.00 | $0.00 |
DisclosureSEC source: 0002036507-26-000007 · wk-form4_1786025757.xml · nonDerivative · entry 1 Fleischhauer Mark · CIK 0002036507 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,367 F1 · shares: The Shares will vest on the earlier of the 2027 Annual Meeting of shareholders and August 4, 2027, subject to the terms of the Restricted Stock Agreement. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 23:04 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 3,500 | $79.83 | $279,402.90 |
DisclosureSEC source: 0002036507-26-000004 · wk-form4_1781737461.xml · nonDerivative · entry 1 Fleischhauer Mark · CIK 0002036507 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,769 Read SEC document |
| August 05, 2025 Filed Aug 7, 2025 20:10 UTC | Anterix Inc. ATEX · Entity 4597 | GrantCommon Stock | 7,767 | $0.00 | $0.00 |
DisclosureSEC source: 0001304492-25-000084 · wk-form4_1754597432.xml · nonDerivative · entry 1 Fleischhauer Mark · CIK 0002036507 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,269 F1 · shares: Represents restricted stock granted to Mr. Fleischhauer as compensation for his services as a non-employee director on the Issuer's board of directors. The restricted stock vests in full on the earlier of (i) August 5, 2026 or (ii) the Issuer's next annual stockholder meeting; provided, however, that if the vesting would otherwise occur on a date that is closed for trading under the Issuer's Insider Trading Policy, the vesting shall be automatically deemed to occur on the next trading day on which the sale of shares of common stock by the Reporting Person in the open market would be permitted under the Issuer's Insider Trading Policy. Read SEC document |
| December 05, 2024 Filed Dec 10, 2024 00:00 UTC | Anterix Inc. ATEX · Entity 4597 | GrantCommon Stock | 5,002 | $0.00 | $0.00 |
DisclosureSEC source: 0001304492-24-000136 · wk-form4_1733788823.xml · nonDerivative · entry 2 Fleischhauer Mark · CIK 0002036507 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,502 F1 · shares: The restricted stock vests in full on the earlier of (i) December 5, 2025 or (ii) the Issuer's next annual stockholder meeting; provided, however, that if the vesting would otherwise occur on a date that is closed for trading under the Issuer's Insider Trading Policy, the vesting shall be automatically deemed to occur on the next trading day on which the sale of shares of common stock by the Reporting Person in the open market would be permitted under the Issuer's Insider Trading Policy. Read SEC document |
| December 05, 2024 Filed Dec 10, 2024 00:00 UTC | Anterix Inc. ATEX · Entity 4597 | PurchaseCommon Stock | 3,500 | $34.19 | $119,665.00 |
DisclosureSEC source: 0001304492-24-000136 · wk-form4_1733788823.xml · nonDerivative · entry 1 Fleischhauer Mark · CIK 0002036507 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,500 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.